Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-23-021978

Director bought 7,000 shares at $1.69 ($11,830)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jaksch Frank L Jr Director 2023-06-12 Purchase +7,000 $1.69 $11,830 231,339 D: show line 1 in the form
Open-market purchases · 7,000 sh · avg $1.69 · $11,830
Loading xslF345X04/wk-form4_1686689397.xml…